In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Pulmonx (LUNG – Research Report), with a price target of ...
Piper Sandler analyst David Westenberg maintained a Buy rating on Adaptive Biotechnologies (ADPT – Research Report) today and set a price ...
Fintel reports that on February 14, 2025, Piper Sandler downgraded their outlook for KORU Medical Systems (NasdaqCM:KRMD) ...